US equities
|
NVDA
$239.01
▲+0.05%
MU
$1,047.31
▼-1.56%
SPCX
$171.80
▲+0.41%
MRVL
$287.09
▲+5.84%
AMD
$649.05
▲+2.74%
INTC
$112.44
▼-3.23%
SNDK
$1,661.53
▼-2.50%
AVGO
$375.74
▲+3.65%
NVDA
$239.01
▲+0.05%
MU
$1,047.31
▼-1.56%
SPCX
$171.80
▲+0.41%
MRVL
$287.09
▲+5.84%
AMD
$649.05
▲+2.74%
INTC
$112.44
▼-3.23%
SNDK
$1,661.53
▼-2.50%
AVGO
$375.74
▲+3.65%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Alejandro Antalich
Recent news which mentions Alejandro Antalich
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
Market News
BMNDF
5/MeO/DMT
From
Benzinga